|
|
| Readers of Life Science Connect communities tell us that our webinars are helpful, informative, and serve as valuable tools for evaluating solutions and suppliers. Below are just a few of the recent Cell & Gene webinars that have taken place on our communities. |
|
|
|
Can an expedited approach be used to develop curative therapies for rare diseases? Access a thorough investigation that delves into the crucial factors for speeding up the development of curative therapies, highlighting the strategic contribution CDMOs can make in this process. |
|
|
|
Inadequate preclinical planning and process development can stall advanced therapy development. Leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using DoE, thereby reducing variability and risk. |
|
|
|
To meet the demands of the early phase market, flexible viral vector drug candidate screening and feasibility studies can help to quickly overcome preclinical and Phase 1 hurdles. Explore how a strategic, effective approach for early stage development can propel therapies to the clinic and the market. |
|
|
|
Distinguish and determine the quantities of AAV species. Explore how to implement analysis using sedimentation velocity analytical ultracentrifugation (SV-AUC) to characterize AAV size distributions using multiple detection wavelengths to identify various fill states in AAV preparation. |
|
|
